Vimarsana
Biggest News Aggregation in the World

Page 28 - Syntax Advisors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Syntax Advisors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Syntax Advisors Today - Breaking & Trending Today

Solidarity Wealth LLC Sells 108 Shares of AbbVie Inc. (NYSE:ABBV) - Vimarsana News

Solidarity Wealth LLC Sells 108 Shares of AbbVie Inc. (NYSE:ABBV)

Solidarity Wealth LLC trimmed its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 1.6% in the third quarter, HoldingsChannel reports. The firm owned 6,740 shares of the company’s stock after selling 108 shares during the quarter. Solidarity Wealth LLC’s holdings in AbbVie were worth $1,005,000 as of its most recent filing with […]

Alhambra Investment Partners LLC Cuts Stake in AbbVie Inc. (NYSE:ABBV) - Vimarsana News

Alhambra Investment Partners LLC Cuts Stake in AbbVie Inc. (NYSE:ABBV)

Alhambra Investment Partners LLC reduced its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 2.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,763 shares of the company’s stock after selling 69 shares during the quarter. Alhambra Investment Partners LLC’s holdings […]

Cedar Brook Financial Partners LLC Reduces Holdings in AbbVie Inc. (NYSE:ABBV) - Vimarsana News

Cedar Brook Financial Partners LLC Reduces Holdings in AbbVie Inc. (NYSE:ABBV)

Cedar Brook Financial Partners LLC trimmed its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 9.3% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,319 shares of the company’s stock after selling 339 shares during the quarter. Cedar Brook Financial Partners […]

Nektar Therapeutics (NASDAQ:NKTR) Receives $3.00 Consensus Price Target from Brokerages - Vimarsana News

Nektar Therapeutics (NASDAQ:NKTR) Receives $3.00 Consensus Price Target from Brokerages

Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) have been assigned an average rating of “Reduce” from the seven brokerages that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and one has assigned a buy recommendation to […]

Impact Partnership Wealth LLC Buys 301 Shares of AbbVie Inc. (NYSE:ABBV) - Vimarsana News

Impact Partnership Wealth LLC Buys 301 Shares of AbbVie Inc. (NYSE:ABBV)

Impact Partnership Wealth LLC boosted its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 7.3% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,447 shares of the company’s stock after purchasing an additional 301 shares during the quarter. Impact Partnership Wealth LLC’s holdings […]